First-In-Class Small Molecule Modulator of Neutrophil Trafficking and Activation
Preclinical
IND Enabling
Phase 1
Phase 2
Phase 3
ADS051
Publications
ADS051, AN ORAL, GUT-RESTRICTED, SMALL MOLECULE NEUTROPHIL MODULATOR IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS RECEIVING MULTIPLE ASCENDING DOSES |
---|
Safety, tolerability and pharmacokinetics of BT051, an oral inhibitor of neutrophil migration and activation in clinical development for Inflammatory Bowel Disease |
---|